PPT-Comparison of INSTI vs INSTI

QDMRK SPRING2 ONCEMRK GSUS3801489 GSUS3801490 GSUS3801490 Design Objective Non inferiority of BICFTAF at W48 HIV RNA lt 50 cmL by intention to treat snapshot analysis lower margin of the 2sided 95002 CI for . wwwiededuhkaclass of 6 Authentic Learning What is Authentic Learning Authentic learning means learning which happens by actually participating and working on real world problems it engages learners by the opportunities of solving real world complex boehmifpunistuttgartde Commission V WG V4 KEY WORDS Range Data LIDAR Building Faade Modelling Matching ABSTRACT In recent years the demand for highly de tailed building models has clearly risen Most of the details which characterize a bu ilding come So that the products of inertia terms are zero, only the moments of terms of inertia are present. Then the moments of inertia of this in the various directions are I (Refer Slide Time: 03:30) If this 


\n
\n
\n

  


 \r 

  \r 

! \n\n

\n
\n 
\n
 ! 
3


 \r
\n 

\n 
 

\n examples are more favorable in earlier stages. The implications for instructional design are that (a) initially, worked-out steps should be presented together with self-explanation prompts, and (b) wh history, so that institutions once established have long-run effects on economic performance,and these effects linger even after the original institutions decay or disappear. This has beenalso confirm FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . Design. Objective. Non inferiority of DTG at W48: % HIV RNA < 50 c/mL by intention to treat, snapshot analysis (1-sided significance level of 2.5%, lower margin of the 95% CI for the difference = -12%, 90% power). FAT TAILSSPRING 2005 FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . Design. Objective. Non inferiority of DTG/ABC/3TC at W48: % HIV RNA < 50 c/mL by intention. to treat, snapshot analysis (lower margin of the 2-sided 95% CI for the difference = - 12%). QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Objective. Non inferiority of RAL QD: % HIV RNA < 40 c/mL by ITT, NC=F . (lower margin of the 2-sided 95% CI for the difference = - 10%, 90% power). RAL 1200 mg ** QD + . FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA . Squires K. Lancet HIV 2016; 3(9):e410-e420. Design. Objective. Non inferiority of EVG/C/FTC/TDF at W48: % HIV RNA < 50 c/. mL. by intention. to treat, snapshot analysis (lower margin of the 2-sided 95% CI for the difference = -12%). FLAMINGO. GS-236-0103. ACTG A5257. . WAVES. Lennox JL. Ann Intern Med 2014;161:461-71. ACTG A5257. Design. Objective. Evaluate regimen equivalence regarding . virologic. efficacy and tolerability over 96 weeks, by intention-to-treat analysis. Equivalence = 2-sided 97.5% CI on the . STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. NEJM 2013;369:1807-18. Design. Objective. Non inferiority of DTG at W48: % HIV RNA < 50 c/mL by intention to treat, snapshot analysis (1-sided significance level of 2.5%, lower margin of . Dathan M. Byonanebye, Mark N. Polizzotto, Fernando Maltez, Andri Rauch, Katharina Grabmeier-Pfistershammer, Ferdinand Wit, Stéphane De Wit, Antonella Castagna, Antonella . D’Arminio. Monforte, Cristina Mussini, Jan-Christian Wasmuth, Eric .